Mora, Barbara
Bucelli, Cristina
Cattaneo, Daniele
Bellani, Valentina
Versino, Francesco
Barbullushi, Kordelia
Fracchiolla, Nicola
Iurlo, Alessandra
Passamonti, Francesco
Funding for this research was provided by:
Università degli Studi di Milano
Article History
Accepted: 2 July 2024
First Online: 24 August 2024
Declarations
:
: The authors do not have existing conflicts. B.M. received honoraria during the last two years for lectures from Novartis. C.B. received honoraria during the last two years from Incyte, Novartis, and Pfizer. A.I. received honoraria during the last two years for lectures from Incyte, Novartis, Bristol-Myers Squibb, GSK, Pfizer, AOP Health and for advisory boards from Incyte, Novartis, Bristol-Myers Squibb, AOP Health. F.P. received honoraria during the last two years for lectures from Novartis, Bristol-Myers Squibb, Abbvie, GSK, Janssen, AOP Orphan and for advisory boards from Novartis, Bristol-Myers Squibb/ Celgene, GSK, Abbvie, AOP Orphan, Janssen, Karyiopharma, Kyowa Kirin and MEI, Sumitomo, Kartos.